Immunohistochemical Expression and Serum Levels of CD44 as Prognostic Indicators in Patients with Non-Small Cell Lung Cancer

Publisher： Karger

E-ISSN： 1423-0232|90|6|327-338

ISSN： 0030-2414

Source： Oncology, Vol.90, Iss.6, 2016-05, pp. : 327-338

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Elevated serum C‐reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non‐small cell lung cancer

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. 4, 2015-12 ,pp. : e22-e30

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pretreatment Serum Levels of Cytokines and Cytokine Receptors in Patients with Non-Small Cell Lung Cancer, and Correlations with Clinicopathological Features and Prognosis

By  

Oncology, Vol. 70, Iss. 2, 2006-05 ,pp. : 115-125

Karger

Access to resources Recommend Favorite

Prognostic Relevance of Altered pRb and p53 Protein Expression in Surgically Treated Non-Small Cell Lung Cancer Patients

By  

Oncology, Vol. 67, Iss. 1, 2004-10 ,pp. : 60-66

Karger

Access to resources Recommend Favorite

Elevated Serum Sialyl Lewis X-i Antigen Levels in Non-Small Cell Lung Cancer with Lung Metastasis

By  

Respiration, Vol. 65, Iss. 4, 1998-09 ,pp. : 295-298

Karger

Access to resources Recommend Favorite

Prognostic Value of Synaptophysin and Chromogranin A Expression in Patients Receiving Palliative Chemotherapy for Advanced Non-Small-Cell Lung Cancer

By  

Respiration, Vol. 85, Iss. 4, 2012-04 ,pp. : 289-296

Karger

Access to resources Recommend Favorite